Pharmaceuticals Global Industry Almanac 2019-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,995	657 Pages	MarketLine	September, 2024	MTLN19325940

Best Price Guarantee
Price	from $2,995
Length	657 Pages
Publisher	MarketLine
Published Date	September, 2024
SKU	MTLN19325940

Pharmaceuticals Global Industry Almanac 2019-2028

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
All market data and forecasts are adjusted for inflation and all currency conversions used in the creation of this report have been calculated using yearly annual average exchange rates.
The global pharmaceuticals market registered revenue of $1,380 billion in 2023, representing a compound annual growth rate (CAGR) of 3.1% between 2018 and 2023.
North America dominated the global pharmaceuticals market in 2023, accounting for the largest share of 39.6%.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the global pharmaceuticals market by value in 2023?
What will be the size of the global pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the global pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in the global pharmaceuticals market?

1 EXECUTIVE SUMMARY: 1.1. Market value; 1.2. Market value forecast; 1.3. Geography segmentation; 1.4. Market share; 1.5. Competitive landscape
2 Introduction: 2.1. What is this report about?; 2.2. Who is the target reader?; 2.3. How to use this report; 2.4. Definitions
3 Global Pharmaceuticals: 3.1. Market Overview; 3.2. Market Data; 3.3. Market Segmentation; 3.4. Market outlook; 3.5. Five forces analysis
4 Macroeconomic Indicators: 4.1. Country data
5 Pharmaceuticals in Asia-Pacific: 5.1. Market Overview; 5.2. Market Data; 5.3. Market Segmentation; 5.4. Market outlook; 5.5. Five forces analysis
6 Pharmaceuticals in Europe: 6.1. Market Overview; 6.2. Market Data; 6.3. Market Segmentation; 6.4. Market outlook; 6.5. Five forces analysis
7 Macroeconomic Indicators: 7.1. Country data
8 Pharmaceuticals in France: 8.1. Market Overview; 8.2. Market Data; 8.3. Market Segmentation; 8.4. Market outlook; 8.5. Five forces analysis
9 Macroeconomic Indicators: 9.1. Country data
10 Pharmaceuticals in Germany: 10.1. Market Overview; 10.2. Market Data; 10.3. Market Segmentation; 10.4. Market outlook; 10.5. Five forces analysis
11 Macroeconomic Indicators: 11.1. Country data
12 Pharmaceuticals in Australia: 12.1. Market Overview; 12.2. Market Data; 12.3. Market Segmentation; 12.4. Market outlook; 12.5. Five forces analysis
13 Macroeconomic Indicators: 13.1. Country data
14 Pharmaceuticals in Brazil: 14.1. Market Overview; 14.2. Market Data; 14.3. Market Segmentation; 14.4. Market outlook; 14.5. Five forces analysis
15 Macroeconomic Indicators: 15.1. Country data
16 Pharmaceuticals in Canada: 16.1. Market Overview; 16.2. Market Data; 16.3. Market Segmentation; 16.4. Market outlook; 16.5. Five forces analysis
17 Macroeconomic Indicators: 17.1. Country data
18 Pharmaceuticals in China: 18.1. Market Overview; 18.2. Market Data; 18.3. Market Segmentation; 18.4. Market outlook; 18.5. Five forces analysis
19 Macroeconomic Indicators: 19.1. Country data
20 Pharmaceuticals in India: 20.1. Market Overview; 20.2. Market Data; 20.3. Market Segmentation; 20.4. Market outlook; 20.5. Five forces analysis
21 Macroeconomic Indicators: 21.1. Country data
22 Pharmaceuticals in Indonesia: 22.1. Market Overview; 22.2. Market Data; 22.3. Market Segmentation; 22.4. Market outlook; 22.5. Five forces analysis
23 Macroeconomic Indicators: 23.1. Country data
24 Pharmaceuticals in Italy: 24.1. Market Overview; 24.2. Market Data; 24.3. Market Segmentation; 24.4. Market outlook; 24.5. Five forces analysis
25 Macroeconomic Indicators: 25.1. Country data
26 Pharmaceuticals in Japan: 26.1. Market Overview; 26.2. Market Data; 26.3. Market Segmentation; 26.4. Market outlook; 26.5. Five forces analysis
27 Macroeconomic Indicators: 27.1. Country data
28 Pharmaceuticals in Mexico: 28.1. Market Overview; 28.2. Market Data; 28.3. Market Segmentation; 28.4. Market outlook; 28.5. Five forces analysis
29 Macroeconomic Indicators: 29.1. Country data
30 Pharmaceuticals in The Netherlands: 30.1. Market Overview; 30.2. Market Data; 30.3. Market Segmentation; 30.4. Market outlook; 30.5. Five forces analysis
31 Macroeconomic Indicators: 31.1. Country data
32 Pharmaceuticals in North America: 32.1. Market Overview; 32.2. Market Data; 32.3. Market Segmentation; 32.4. Market outlook; 32.5. Five forces analysis
33 Pharmaceuticals in Russia: 33.1. Market Overview; 33.2. Market Data; 33.3. Market Segmentation; 33.4. Market outlook; 33.5. Five forces analysis
34 Macroeconomic Indicators: 34.1. Country data
35 Pharmaceuticals in Scandinavia: 35.1. Market Overview; 35.2. Market Data; 35.3. Market Segmentation; 35.4. Market outlook; 35.5. Five forces analysis
36 Pharmaceuticals in Singapore: 36.1. Market Overview; 36.2. Market Data; 36.3. Market Segmentation; 36.4. Market outlook; 36.5. Five forces analysis
37 Macroeconomic Indicators: 37.1. Country data
38 Pharmaceuticals in South Africa: 38.1. Market Overview; 38.2. Market Data; 38.3. Market Segmentation; 38.4. Market outlook; 38.5. Five forces analysis
39 Macroeconomic Indicators: 39.1. Country data
40 Pharmaceuticals in South Korea: 40.1. Market Overview; 40.2. Market Data; 40.3. Market Segmentation; 40.4. Market outlook; 40.5. Five forces analysis
41 Macroeconomic Indicators: 41.1. Country data
42 Pharmaceuticals in Spain: 42.1. Market Overview; 42.2. Market Data; 42.3. Market Segmentation; 42.4. Market outlook; 42.5. Five forces analysis
43 Macroeconomic Indicators: 43.1. Country data
44 Pharmaceuticals in Turkey: 44.1. Market Overview; 44.2. Market Data; 44.3. Market Segmentation; 44.4. Market outlook; 44.5. Five forces analysis
45 Macroeconomic Indicators: 45.1. Country data
46 Pharmaceuticals in The United Kingdom: 46.1. Market Overview; 46.2. Market Data; 46.3. Market Segmentation; 46.4. Market outlook; 46.5. Five forces analysis
47 Macroeconomic Indicators: 47.1. Country data
48 Pharmaceuticals in The United States: 48.1. Market Overview; 48.2. Market Data; 48.3. Market Segmentation; 48.4. Market outlook; 48.5. Five forces analysis
49 Macroeconomic Indicators: 49.1. Country data
50 Company Profiles: 50.1. BASF SE; 50.2. Sinopharm Group Co Ltd; 50.3. F. Hoffmann-La Roche Ltd; 50.4. The Procter & Gamble Co; 50.5. Shanghai Pharmaceuticals Holding Co Ltd; 50.6. CSPC Pharmaceutical Group Ltd; 50.7. Takeda Pharmaceutical Co Ltd; 50.8. Novartis AG; 50.9. GSK plc; 50.10. AstraZeneca Plc; 50.11. Sanofi; 50.12. Roche Holding AG; 50.13. Laboratoires Pierre Fabre SA; 50.14. Ipsen SA; 50.15. Les Laboratoires Servier SAS; 50.16. Bayer AG; 50.17. Boehringer Ingelheim GmbH; 50.18. CSL Ltd; 50.19. Astrazeneca Pty Ltd; 50.20. Mayne Pharma Group Ltd; 50.21. Hypera SA; 50.22. Ache Laboratorios Farmaceuticos SA; 50.23. EMS Sigma Pharma; 50.24. Eurofarma Laboratorios SA; 50.25. Johnson & Johnson; 50.26. Sanofi-Aventis Canada Inc; 50.27. Apotex Inc; 50.28. Bausch Health Companies Inc; 50.29. Jiangsu Hengrui Medicine Co Ltd; 50.30. Lupin Ltd; 50.31. Cipla Ltd; 50.32. Dr. Reddy's Laboratories Ltd; 50.33. PT Kalbe Farma Tbk; 50.34. PT Kimia Farma Tbk; 50.35. PT Tempo Scan Pacific Tbk; 50.36. Pfizer Italia Srl; 50.37. A. Menarini Industrie Farmaceutiche Riunite Srl; 50.38. Chiesi Farmaceutici SpA; 50.39. Recordati SpA; 50.40. Daiichi Sankyo Co Ltd; 50.41. Astellas Pharma Inc; 50.42. Otsuka Holdings Co Ltd; 50.43. Sanofi-Aventis de Mexico SA de CV; 50.44. Genomma Lab Internacional SAB de CV; 50.45. Bayer de Mexico SA de CV; 50.46. Boehringer Ingelheim Mexico; 50.47. Pfizer BV; 50.48. Astellas Pharma Europe Ltd; 50.49. Merck & Co Inc; 50.50. AbbVie Inc; 50.51. Pfizer Inc; 50.52. Bristol-Myers Squibb Co; 50.53. OTC Pharma International BV; 50.54. Pharmstandard; 50.55. Binnopharm Group; 50.56. Novo Nordisk AS; 50.57. H. Lundbeck AS; 50.58. Pfizer Laboratories (Pty) Ltd; 50.59. Aspen Pharmacare Holdings Ltd; 50.60. Adcock Ingram Holdings Ltd; 50.61. Chong Kun Dang Pharmaceutical Corp.; 50.62. Yuhan Corp; 50.63. Celltrion Inc; 50.64. Hanmi Pharmaceuticals Co Ltd; 50.65. Grifols SA; 50.66. Almirall SA; 50.67. Laboratorios Farmaceuticos Rovi SA; 50.68. Abdi Ibrahim Ilac Sanayi ve Ticaret AS; 50.69. Deva Holding AS
51 Appendix: 51.1. Methodology; 51.2. About MarketLine
List of Tables: Table 1: Global pharmaceuticals market value: $ billion, 2018-23; Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2023; Table 3: Global pharmaceuticals market share: % share, by value, 2023; Table 4: Global pharmaceuticals market value forecast: $ billion, 2023-28; Table 5: Global Size of Population (million), 2019-23; Table 6: Global real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 7: Global GDP (Current Prices, $ Billion), 2019-23; Table 8: Global Inflation, 2019-23; Table 9: Global Consumer Price Index (Absolute), 2019-23; Table 10: Global exchange rate, 2018-23; Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2018-23; Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2023; Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2023-28; Table 14: Europe pharmaceuticals market value: $ billion, 2018-23; Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2023; Table 16: Europe pharmaceuticals market value forecast: $ billion, 2023-28; Table 17: Europe Size of Population (million), 2019-23; Table 18: Europe real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 19: Europe GDP (Current Prices, $ Billion), 2019-23; Table 20: Europe Inflation, 2019-23; Table 21: Europe Consumer Price Index (Absolute), 2019-23; Table 22: Europe exchange rate, 2018-23; Table 23: France pharmaceuticals market value: $ billion, 2018-23; Table 24: France pharmaceuticals market geography segmentation: $ billion, 2023; Table 25: France pharmaceuticals market value forecast: $ billion, 2023-28; Table 26: France Size of Population (million), 2019-23; Table 27: France real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 28: France GDP (Current Prices, $ Billion), 2019-23; Table 29: France Inflation, 2019-23; Table 30: France Consumer Price Index (Absolute), 2019-23; Table 31: France exchange rate, 2018-23; Table 32: Germany pharmaceuticals market value: $ billion, 2018-23; Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2023; Table 34: Germany pharmaceuticals market value forecast: $ billion, 2023-28; Table 35: Germany Size of Population (million), 2019-23; Table 36: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 37: Germany GDP (Current Prices, $ Billion), 2019-23; Table 38: Germany Inflation, 2019-23; Table 39: Germany Consumer Price Index (Absolute), 2019-23; Table 40: Germany exchange rate, 2018-23; Table 41: Australia pharmaceuticals market value: $ billion, 2018-23; Table 42: Australia pharmaceuticals market geography segmentation: $ billion, 2023; Table 43: Australia pharmaceuticals market value forecast: $ billion, 2023-28; Table 44: Australia Size of Population (million), 2019-23; Table 45: Australia real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 46: Australia GDP (Current Prices, $ Billion), 2019-23; Table 47: Australia Inflation, 2019-23; Table 48: Australia Consumer Price Index (Absolute), 2019-23; Table 49: Australia exchange rate, 2018-23; Table 50: Brazil pharmaceuticals market value: $ billion, 2018-23; Table 51: Brazil pharmaceuticals market geography segmentation: $ billion, 2023; Table 52: Brazil pharmaceuticals market value forecast: $ billion, 2023-28; Table 53: Brazil Size of Population (million), 2019-23; Table 54: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 55: Brazil GDP (Current Prices, $ Billion), 2019-23; Table 56: Brazil Inflation, 2019-23; Table 57: Brazil Consumer Price Index (Absolute), 2019-23; Table 58: Brazil exchange rate, 2018-23; Table 59: Canada pharmaceuticals market value: $ billion, 2018-23; Table 60: Canada pharmaceuticals market geography segmentation: $ billion, 2023; Table 61: Canada pharmaceuticals market value forecast: $ billion, 2023-28; Table 62: Canada Size of Population (million), 2019-23; Table 63: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 64: Canada GDP (Current Prices, $ Billion), 2019-23; Table 65: Canada Inflation, 2019-23; Table 66: Canada Consumer Price Index (Absolute), 2019-23; Table 67: Canada exchange rate, 2018-23; Table 68: China pharmaceuticals market value: $ billion, 2018-23; Table 69: China pharmaceuticals market geography segmentation: $ billion, 2023; Table 70: China pharmaceuticals market value forecast: $ billion, 2023-28; Table 71: China Size of Population (million), 2019-23; Table 72: China real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 73: China GDP (Current Prices, $ Billion), 2019-23; Table 74: China Inflation, 2019-23; Table 75: China Consumer Price Index (Absolute), 2019-23; Table 76: China exchange rate, 2018-23; Table 77: India pharmaceuticals market value: $ billion, 2018-23; Table 78: India pharmaceuticals market geography segmentation: $ billion, 2023; Table 79: India pharmaceuticals market value forecast: $ billion, 2023-28; Table 80: India Size of Population (million), 2019-23; Table 81: India real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 82: India GDP (Current Prices, $ Billion), 2019-23; Table 83: India Inflation, 2019-23; Table 84: India Consumer Price Index (Absolute), 2019-23; Table 85: India exchange rate, 2018-23; Table 86: Indonesia pharmaceuticals market value: $ billion, 2018-23; Table 87: Indonesia pharmaceuticals market geography segmentation: $ billion, 2023; Table 88: Indonesia pharmaceuticals market value forecast: $ billion, 2023-28; Table 89: Indonesia Size of Population (million), 2019-23; Table 90: Indonesia real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 91: Indonesia GDP (Current Prices, $ Billion), 2019-23; Table 92: Indonesia Inflation, 2019-23; Table 93: Indonesia Consumer Price Index (Absolute), 2019-23
List of Figures: Figure 1: Global pharmaceuticals market value: $ billion, 2018-23; Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 3: Global pharmaceuticals market share: % share, by value, 2023; Figure 4: Global pharmaceuticals market value forecast: $ billion, 2023-28; Figure 5: Forces driving competition in the global pharmaceuticals market, 2023; Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2023; Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2023; Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2023; Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2023; Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2023; Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2018-23; Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2023-28; Figure 14: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2023; Figure 15: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2023; Figure 16: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2023; Figure 17: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2023; Figure 18: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2023; Figure 19: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2023; Figure 20: Europe pharmaceuticals market value: $ billion, 2018-23; Figure 21: Europe pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 22: Europe pharmaceuticals market value forecast: $ billion, 2023-28; Figure 23: Forces driving competition in the pharmaceuticals market in Europe, 2023; Figure 24: Drivers of buyer power in the pharmaceuticals market in Europe, 2023; Figure 25: Drivers of supplier power in the pharmaceuticals market in Europe, 2023; Figure 26: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2023; Figure 27: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2023; Figure 28: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2023; Figure 29: France pharmaceuticals market value: $ billion, 2018-23; Figure 30: France pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 31: France pharmaceuticals market value forecast: $ billion, 2023-28; Figure 32: Forces driving competition in the pharmaceuticals market in France, 2023; Figure 33: Drivers of buyer power in the pharmaceuticals market in France, 2023; Figure 34: Drivers of supplier power in the pharmaceuticals market in France, 2023; Figure 35: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2023; Figure 36: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2023; Figure 37: Drivers of degree of rivalry in the pharmaceuticals market in France, 2023; Figure 38: Germany pharmaceuticals market value: $ billion, 2018-23; Figure 39: Germany pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 40: Germany pharmaceuticals market value forecast: $ billion, 2023-28; Figure 41: Forces driving competition in the pharmaceuticals market in Germany, 2023; Figure 42: Drivers of buyer power in the pharmaceuticals market in Germany, 2023; Figure 43: Drivers of supplier power in the pharmaceuticals market in Germany, 2023; Figure 44: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2023; Figure 45: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2023; Figure 46: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2023; Figure 47: Australia pharmaceuticals market value: $ billion, 2018-23; Figure 48: Australia pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 49: Australia pharmaceuticals market value forecast: $ billion, 2023-28; Figure 50: Forces driving competition in the pharmaceuticals market in Australia, 2023; Figure 51: Drivers of buyer power in the pharmaceuticals market in Australia, 2023; Figure 52: Drivers of supplier power in the pharmaceuticals market in Australia, 2023; Figure 53: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2023; Figure 54: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2023; Figure 55: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2023; Figure 56: Brazil pharmaceuticals market value: $ billion, 2018-23; Figure 57: Brazil pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 58: Brazil pharmaceuticals market value forecast: $ billion, 2023-28; Figure 59: Forces driving competition in the pharmaceuticals market in Brazil, 2023; Figure 60: Drivers of buyer power in the pharmaceuticals market in Brazil, 2023; Figure 61: Drivers of supplier power in the pharmaceuticals market in Brazil, 2023; Figure 62: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2023; Figure 63: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2023; Figure 64: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2023; Figure 65: Canada pharmaceuticals market value: $ billion, 2018-23; Figure 66: Canada pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 67: Canada pharmaceuticals market value forecast: $ billion, 2023-28; Figure 68: Forces driving competition in the pharmaceuticals market in Canada, 2023; Figure 69: Drivers of buyer power in the pharmaceuticals market in Canada, 2023; Figure 70: Drivers of supplier power in the pharmaceuticals market in Canada, 2023; Figure 71: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2023; Figure 72: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2023; Figure 73: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2023; Figure 74: China pharmaceuticals market value: $ billion, 2018-23; Figure 75: China pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 76: China pharmaceuticals market value forecast: $ billion, 2023-28; Figure 77: Forces driving competition in the pharmaceuticals market in China, 2023; Figure 78: Drivers of buyer power in the pharmaceuticals market in China, 2023; Figure 79: Drivers of supplier power in the pharmaceuticals market in China, 2023; Figure 80: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2023; Figure 81: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2023; Figure 82: Drivers of degree of rivalry in the pharmaceuticals market in China, 2023; Figure 83: India pharmaceuticals market value: $ billion, 2018-23; Figure 84: India pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 85: India pharmaceuticals market value forecast: $ billion, 2023-28; Figure 86: Forces driving competition in the pharmaceuticals market in India, 2023; Figure 87: Drivers of buyer power in the pharmaceuticals market in India, 2023; Figure 88: Drivers of supplier power in the pharmaceuticals market in India, 2023; Figure 89: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2023; Figure 90: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2023; Figure 91: Drivers of degree of rivalry in the pharmaceuticals market in India, 2023; Figure 92: Indonesia pharmaceuticals market value: $ billion, 2018-23; Figure 93: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2023; Figure 94: Indonesia pharmaceuticals market value forecast: $ billion, 2023-28